The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Amyloid β-Protein Fibrillogenesis
Open accessAbstract
Alzheimer's disease is characterized by extensive cerebral amyloid deposition. Amyloid deposits associated with damaged neuropil and blood vessels contain abundant fibrils formed by the amyloid beta-protein (Abeta). Fibrils, both in vitro and in vivo, are neurotoxic. For this reason, substantial effort has been expended to develop therapeutic approaches to control Abeta production and amyloidogenesis. Achievement of the latter goal is facilitated by a rigorous mechanistic understanding of the fibrillogenesis process. Recently, we discovered a novel intermediate in the pathway of Abeta fibril formation, the amyloid protofibril (Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) J. Biol. Chem. 272, 22364-22372). We report here results of studies of the assembly, structure, and biological activity of these polymers. We find that protofibrils: 1) are in equilibrium with low molecular weight Abeta (monomeric or dimeric); 2) have a secondary structure characteristic of amyloid fibrils; 3) appear as beaded chains in rotary shadowed preparations examined electron microscopically; 4) give rise to mature amyloid-like fibrils; and 5) affect the normal metabolism of cultured neurons. The implications of these results for the development of therapies for Alzheimer's disease and for our understanding of fibril assembly are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“oligomeric Aβ rather than fibril Aβ is regarded as the toxic species of this peptide [143,144,145,146].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [144]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Hansen, M., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,488
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Pan, K. M., Baldwin, M. A., Nguyen, J. T., Gasset, M., Serban, A. V., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10962 · Cited by 2,281
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Flagged first, then by citations
Research works printed but not linked: 4
- Alzheimer, 1906, Neurol. Centr., 23, 1129
- Lomakin, 1999, Methods Enzymol., 309
- Naiki, 1996, Lab. Invest., 74, 374
- Hartley, 1998, Soc. Neurosci., 24, 508
Cited by
Sorted by citations
Items 401–500 of 1,000
Lynch, I. (2006) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2006.06.008 · Cited by 65
Environment‐ and mutation‐dependent aggregation behavior of Alzheimer amyloid β‐protein
Yamamoto, N., Hasegawa, K., Matsuzaki, K., Naiki, H., & Yanagisawa, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02459.x · Cited by 67
Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
Carlo, M. D., Giacomazza, D., & Biagio, P. L. S. (2012) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/24/24/244102 · Cited by 67
Tauroursodeoxycholic acid prevents E22Q Alzheimer’s Aβ toxicity in human cerebral endothelial cells
Viana, R. J. S., Nunes, A. F., Castro, R. E., Ramalho, R. M., Meyerson, J. L., Fossati, S., Ghiso, J. A., Rostagno, A. A., & Rodrigues, C. M. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8746-x · Cited by 64
A comparative molecular dynamics analysis of the amyloid β-peptide in a lipid bilayer
Lemkul, J. A., & Bevan, D. R. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.11.004 · Cited by 64
Strategic Design of Amyloid-β Species Fluorescent Probes for Alzheimer’s Disease
Su, D., Diao, W., Li, J., Pan, L., Zhang, X., Wu, X., & Mao, W. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00810 · Cited by 64
Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer’s disease
Chauhan, V. P. S., Ji, L., & Chauhan, A. (2008) · Biogerontology · doi:10.1007/s10522-008-9169-z · Cited by 63
Manna, M., & Mukhopadhyay, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071308 · Cited by 63
Iron chelation as a potential therapy for neurodegenerative disease
Hider, R. C., Ma, Y., Molina‐Holgado, F., Gaeta, A., & Roy, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361304 · Cited by 64
Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (AlATP)
Exley, C., & Korchazhkina, O. V. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00171-4 · Cited by 63
Merino-Zamorano, C., Fernández-de Retana, S., Montañola, A., Batlle, A., Saint-Pol, J., Mysiorek, C., Gosselet, F., Montaner, J., & Hernández-Guillamon, M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150976 · Cited by 63
Amyloid-beta immunotherapy: the hope for Alzheimer disease?
Barrera-Ocampo, A. A., & Lopera, F. J. (2016) · Colombia medica · doi:10.25100/cm.v47i4.2640 · Cited by 64
Devanathan, S., Salamon, Z., Lindblom, G., Gröbner, G., & Tollin, G. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05162.x · Cited by 69
Miller, Y., Ma, B., & Nussinov, R. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1100273 · Cited by 62
Troesch, B., Weber, P., & Mohajeri, M. H. (2016) · Nutrients · doi:10.3390/nu8120803 · Cited by 63
Amyloid β-Peptide Oligomerization in S ilico : Dimer and Trimer
Jang, S., & Shin, S. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp055568e · Cited by 62
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
Oakley, S. S., Maina, M. B., Marshall, K. E., Al‐Hilaly, Y. K., Harrington, C., Wischik, C. M., & Serpell, L. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590754 · Cited by 59
Fibrillation in Human Serum Albumin Is Enhanced in the Presence of Copper(II)
PANDEY, N. K., Ghosh, S., & Dasgupta, S. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp103876p · Cited by 61
Rivière, C., Delaunay, J.-C., Immel, F., Cullin, C., & Monti, J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9883-6 · Cited by 63
Role of water‐soluble amyloid‐β in the pathogenesis of Alzheimer's disease
Tabaton, M., & Piccini, A. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00428.x · Cited by 65
Srisailam, S., Wang, H.-M., Kumar, T. K. S., Rajalingam, D., Vaithiyalingam, S., Sheu, H., Chang, Y., & Yu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110762200 · Cited by 61
On the subject of rigor in the study of amyloid β-protein assembly
Teplow, D. B. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt203 · Cited by 60
Self-citationConformational Intermediate of the Amyloidogenic Protein β2-Microglobulin at Neutral pH
Heegaard, N. H. H., Sen, J. W., Kaarsholm, N. C., & Nissen, M. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104452200 · Cited by 61
Puławski, W., Ghoshdastider, U., Andrisano, V., & Filipek, S. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9549-3 · Cited by 60
Dulin, F., Léveillé, F., Becerril-Ortega, J., Mornon, J., Buisson, A., Callebaut, I., & Colloc’h, N. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.002 · Cited by 73
Amyloid Fibril Formation by the Glaucoma-Associated Olfactomedin Domain of Myocilin
Orwig, S. D., Perry, C. W., Kim, L. Y., Turnage, K. C., Zhang, R., Vollrath, D., Schmidt‐Krey, I., & Lieberman, R. L. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.016 · Cited by 59
Zhang, A., Qi, W., Good, T. A., & Fernández, E. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.022 · Cited by 60
Oligomerization of β-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types
SIAN, A. K., Frears, E. R., El‐Agnaf, O. M. A., PATEL, B. P., Manca, M. F., Siligardi, G., Hussain, R., & Austen, B. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490299 · Cited by 61
The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly
Messa, M., Colombo, L., Favero, E. D., Cantú, L., Stoilova, T., Cagnotto, A., Rossi, A., Morbin, M., Fede, G. D., Tagliavini, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576256 · Cited by 59
Co‐incorporation of Aβ40 and Aβ42 to form mixed pre‐fibrillar aggregates
Frost, D., Gorman, P. M., Yip, C. M., & Chakrabartty, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03415.x · Cited by 59
Kapurniotu, A., Buck, A. K., Weber, M., Schmauder, A., Hirsch, T., Bernhagen, J., & Tatarek‐Nossol, M. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00022-x · Cited by 59
Bohrmann, B., Adrian, M., Dubochet, J., Kuner, P., Müller, F., Huber, W., Nordstedt, C., & Döbeli, H. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4241 · Cited by 58
Harris, J. R. (2002) · Micron · doi:10.1016/s0968-4328(02)00029-x · Cited by 59
Liu, D., Xu, Y., Yu, F., Liu, H., Shen, X., Chen, K., Ma, J., & Jiang, H. (2006) · Biochemistry · doi:10.1021/bi060955f · Cited by 59
Linker Histone H1 Binds to Disease Associated Amyloid-like Fibrils
Duce, J. A., Smith, D. P., Blake, R. E., Crouch, P. J., Li, Q., Masters, C. L., & Trounce, I. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.038 · Cited by 62
Fluorescence Anisotropy: A Method for Early Detection of Alzheimer β-Peptide (Aβ) Aggregation
Allsop, D., Swanson, L., Moore, S., Davies, Y., York, A., El‐Agnaf, O. M. A., & Soutar, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5123 · Cited by 59
Neurodegenerative pathways as targets for acquired epilepsy therapy development
Casillas-Espinosa, P. M., Ali, I. Y., & O'Brien, T. J. (2020) · Epilepsia Open · doi:10.1002/epi4.12386 · Cited by 59
Misfolding of the amyloid β‐protein: A molecular dynamics study
Flöck, D., Colacino, S., Colombo, G., & Nola, A. D. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20683 · Cited by 58
Synergistic Inhibitory Effect of GQDs–Tramiprosate Covalent Binding on Amyloid Aggregation
Liu, Y., Xu, L.-P., Wang, Q., Yang, B., & Zhang, X. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00439 · Cited by 58
Neuron Specific Toxicity of Oligomeric Amyloid-β: Role for JUN-Kinase and Oxidative Stress
Ebenezer, P. J., Weidner, A. M., LeVine, H., Markesbery, W. R., Murphy, M. P., Zhang, L., Dasuri, K., Fernandez-Kim, S. O., Bruce-Keller, A. J., Gavilán, E., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101161 · Cited by 58
Österlund, N., Lundqvist, M., Ilag, L. L., Gräslund, A., & Emanuelsson, C. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013459 · Cited by 57
Pharmacotherapeutic targets in Alzheimer's disease
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00595.x · Cited by 59
Wilhelmus, M. M. M., van Dam, A., & Drukarch, B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.059 · Cited by 56
Interaction of human stefin B in the prefibrillar oligomeric form with membranes
Anderluh, G., Gutiérrez‐Aguirre, I., Rabzelj, S., Čeru, S., Kopitar‐Jerala, N., Maček, P., Türk, V., & Žerovnik, E. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04717.x · Cited by 57
Pressure-jump NMR Study of Dissociation and Association of Amyloid Protofibrils
Kamatari, Y. O., Yokoyama, S., Tachibana, H., & Akasaka, K. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.04.010 · Cited by 57
Mutant Presenilin 1 Increases the Expression and Activity of BACE1
Giliberto, L., Borghi, R., Piccini, A., Mangerini, R., Sorbi, S., Cirmena, G., Garuti, A., Ghetti, B. F., Tagliavini, F., Mughal, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805685200 · Cited by 56
Computational Study on the Structural Diversity of Amyloid Beta Peptide (Aβ10-35) Oligomers
Jang, S., & Shin, S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp076450w · Cited by 56
Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease
Serrano‐Pozo, A., Mielke, M. L., Muzitansky, A., Gómez‐Isla, T., Growdon, J. H., Bacskai, B. J., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825e77de · Cited by 57
Neurodegeneration and Alzheimer’s disease: the lesson from tauopathies
Sorrentino, G., & Bonavita, V. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0789-x · Cited by 56
Na, J., Song, K., Lee, J.-W., Kim, S., & Kwon, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.026 · Cited by 56
Toxicity mediated by soluble oligomers of β‐amyloid(1–42) on cholinergic SN56.B5.G4 cells
Heinitz, K., Beck, M., Schliebs, R., & Perez-Polo, J. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04015.x · Cited by 58
Bigi, A., Cascella, R., Chiti, F., & Cecchi, C. (2022) · BioEssays · doi:10.1002/bies.202200086 · Cited by 56
Mechanical manipulation of Alzheimer’s amyloid β1–42 fibrils
Karsai, Á., Mártonfalvi, Z., Nagy, A., Grama, L., Penke, B., & Kellermayer, M. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.12.015 · Cited by 55
Dickerson, T. J., & Janda, K. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332847100 · Cited by 55
Chen, Y. R., Huang, H., Chyan, C. L., Shiao, M. S., Lin, T. H., & Chen, Y. C. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj083 · Cited by 54
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Johansson, A., Bergquist, J., Volbracht, C., Päiviö, A., Leist, M., Lannfelt, L., & Westlind‐Danielsson, A. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3280b07c21 · Cited by 53
Gao, M., & Winter, R. (2015) · Journal of Diabetes Research · doi:10.1155/2015/849017 · Cited by 54
Rzepecki, P., Nagel‐Steger, L., Feuerstein, S., Linne, U., Molt, O., Zadmard, R., Aschermann, K., Wehner, M., Schrader, T. H., & Riesner, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405914200 · Cited by 54
Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology
Žerovnik, E., Škarabot, M., Škerget, K., Giannini, S., Žerovnik, E., Škarabot, M., Škerget, K., Giannini, S., Stoka, V., Kokalj, S. J., et al. (2007) · Amyloid · doi:10.1080/13506120701461137 · Cited by 54
Monji, A., Utsumi, H., Ueda, T., Imoto, T., Yoshida, I., Hashioka, S., Tashiro, K., & Tashiro, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00392.x · Cited by 53
Murakami, K. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.940275 · Cited by 53
Mitochondria in Aging and Alzheimer's Disease
Crouch, P. J., Cimdins, K., Duce, J. A., Bush, A. I., & Trounce, I. A. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0592 · Cited by 54
Ly, T., & Julian, R. R. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.07.006 · Cited by 53
Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Twyman, L. J., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00510-x · Cited by 54
Tanaka, M., Machida, Y., Nishikawa, Y., Akagi, T., Hashikawa, T., Fujisawa, T., & Nukina, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209852200 · Cited by 53
Iowa Variant of Familial Alzheimer’s Disease
Tomidokoro, Y., Rostagno, A. A., Neubert, T. A., Lu, Y., Rebeck, G. W., Frangione, B., Greenberg, S. M., & Ghiso, J. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090636 · Cited by 54
Qi, W., Zhang, A., Good, T. A., & Fernández, E. (2009) · Biochemistry · doi:10.1021/bi9006397 · Cited by 52
Schauerte, J. A., Wong, P., Wisser, K. C., Ding, H., Steel, D. G., & Gafni, A. (2010) · Biochemistry · doi:10.1021/bi901444w · Cited by 52
Proinsulin Is Refractory to Protein Fibrillation
Huang, K., Dong, J., Phillips, N. B., CAREY, P. R., & Weiss, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507110200 · Cited by 53
Galante, D., Corsaro, A., Florio, T., Vella, S., Pagano, A., Sbrana, F., Vassalli, M., Perico, A., & D’Arrigo, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.010 · Cited by 51
Hawkes, C. A., Deng, L., Shaw, J. E., Nitz, M., & McLaurin, J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07052.x · Cited by 53
Song, M., Sun, Y., Luo, Y., Zhu, Y., Liu, Y., & Li, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061815 · Cited by 52
Vadukul, D. M., Maina, M. B., Franklin, H., Nardecchia, A., Serpell, L. C., & Marshall, K. E. (2020) · FEBS Letters · doi:10.1002/1873-3468.13919 · Cited by 51
Hamodrakas, S. J., Hoenger, A., & Iconomidou, V. A. (2003) · Journal of Structural Biology · doi:10.1016/j.jsb.2003.10.004 · Cited by 52
The Arctic mutation interferes with processing of the amyloid precursor protein
Stenh, C., Nilsberth, C., ck, J. H., Engvall, B., Nšslund, J., & Lannfelt, L. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00005 · Cited by 52
Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
Tetz, G. V., & Tetz, V. (2021) · Microorganisms · doi:10.3390/microorganisms9061301 · Cited by 50
Jiang, D., Dinh, K. L., Ruthenburg, T. C., Zhang, Y., Su, L., Land, D. P., & Zhou, F. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8085792 · Cited by 51
Hacking the Code of Amyloid Formation
Pastor, M. T., Esteras‐Chopo, A., & Serrano, L. G. (2007) · Prion · doi:10.4161/pri.1.1.4100 · Cited by 51
Rózga, M., & Bal, W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900358j · Cited by 54
Mohanty, J., Choudhury, S., Pal, H., & Bhasikuttan, A. C. (2012) · Chemical Communications · doi:10.1039/c2cc16974f · Cited by 46
Yu, X., Hayden, E. Y., Xia, M., Liang, O., Cheah, L., Teplow, D. B., & Xie, Y. (2018) · Protein Science · doi:10.1002/pro.3434 · Cited by 51
Self-citationThe Toxicity of Misfolded Protein Oligomers Is Independent of Their Secondary Structure
Vivoli, M., Cascella, R., Chen, S. W., Fusco, G., Simone, A. D., Dobson, C. M., Cecchi, C., & Chiti, F. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00324 · Cited by 51
El‐Agnaf, O. M. A., Sheridan, J. M., Sidera, C., Siligardi, G., Hussain, R., Haris, P. I., & Austen, B. (2001) · Biochemistry · doi:10.1021/bi002287i · Cited by 51
Carrotta, R., Carlo, M. D., Manno, M., Montana, G., Picone, P., Romancino, D. P., & Biagio, P. L. S. (2006) · The FASEB Journal · doi:10.1096/fj.06-5716fje · Cited by 50
Rymer, D. L., & Good, T. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005800200 · Cited by 50
Disordered Proteins: Biological Membranes as Two-Dimensional Aggregation Matrices
Byström, R., Aisenbrey, C., Borowik, T., Bokvist, M., Lindström, F., Sani, M., Olofsson, A., & Gröbner, G. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9033-4 · Cited by 50
Talmard, C., Yona, R. L., & Faller, P. (2008) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0461-9 · Cited by 51
Škerget, K., Vilfan, A., Pompe‐Novak, M., Türk, V., Waltho, J. P., Turk, D., & Žerovnik, E. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22156 · Cited by 50
Rivera, E., Straub, J. E., & Thirumalai, D. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.03.039 · Cited by 50
A safer vaccine for Alzheimer’s disease?
Sigurdsson, E. M., Wısnıewskı, T., & Frangione, B. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00124-0 · Cited by 50
Petty, S. A., Adalsteinsson, T., & Decatur, S. M. (2005) · Biochemistry · doi:10.1021/bi047445a · Cited by 50
Ran, C., Zhao, W., Moir, R. D., & Moore, A. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019362 · Cited by 49
Diseases of protein aggregation and the hunt for potential pharmacological agents
Wang, S. S. ‐., Wu, J. W., Yamamoto, S., & Liu, H. (2007) · Biotechnology Journal · doi:10.1002/biot.200700065 · Cited by 49
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Laurent, S., Ejtehadi, M. R., Rezaei, M., Kehoe, P. G., & Mahmoudi, M. (2012) · RSC Advances · doi:10.1039/c2ra01374f · Cited by 51
de Retana, S. F., Cano‐Sarabia, M., Marazuela, P., Sánchez‐Quesada, J. L., García‐León, A., Montañola, A., Montaner, J., Maspoch, D., & Hernández‐Guillamón, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15215-w · Cited by 49
Morel, B., Carrasco, M. P., Jurado, S., Marco, C., & Conejero‐Lara, F. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp02685h · Cited by 50
Intrahippocampal administration of Aβ1–40 impairs spatial learning and memory in hyperglycemic mice
Huang, H.-J., Liang, K.-C., Chen, C., Chen, C., & Hsieh‐Li, H. M. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.11.006 · Cited by 49
Curcumin Scaffold as a Multifunctional Tool for Alzheimer’s Disease Research
Yang, H., Zeng, F., Luo, Y., Zheng, C., Ran, C., & Yang, J. (2022) · Molecules · doi:10.3390/molecules27123879 · Cited by 52
Hernández‐Guillamón, M., Mawhirt, S. L., Fossati, S., Blais, S. P., Parés, M., Peñalba, A., Boada, M., Couraud, P., Neubert, T. A., Montaner, J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135228 · Cited by 49
FTIR spectroscopic studies on aggregation process of the β‐amyloid 11–28 fragment and its variants
Juszczyk, P., Kołodziejczyk, A. S., & Grzonka, Z. (2008) · Journal of Peptide Science · doi:10.1002/psc.1085 · Cited by 50
Metadata
- Authors
- Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B.
- Affiliations
- Brigham and Women's Hospital (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Teplow, David B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 274
- Issue
- 36
- Pages
- 25945-25952
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2073516240
- Cited by
- 1,046
- References
- 65
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 14 · 2023: 15 · 2022: 18 · 2021: 20 · 2020: 24 · 2019: 13 · 2018: 23 · 2017: 26 · 2016: 39 · 2015: 43 · 2014: 38 · 2013: 34 · 2012: 58
- FWCI
- 21.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Amgen
- Brigham and Women's Hospital
- Foundation for Neurologic Diseases
- National Institutes of Health (5p01ag014366-05)
- National Institute on Aging (1PO1 AG14366, 1RO1 AG12749, R01AG012749)
- National Institute of Neurological Disorders and Stroke (R01NS038328, 1RO1 NS38328)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- amyloid-beta, fibril formation, amyloid protofibrils, Alzheimer's disease, amyloid deposition, neurotoxicity, secondary structure, neuronal metabolism, amyloid fibril formation, Alzheimer's disease treatment
- MeSH terms
- Alzheimer Disease, Humans, Amyloid beta-Peptides, Protein Structure, Secondary, Protein Folding, Dimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review